Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 5, 2019 | Hummingbird Bioscience | $19.0M Series B | G.N. Tech Venture Capital, Mirae Asset Venture Investment | DAValue-GiltEdge, Delian Capital, HB Investment, Heritas Capital, Kiwoom Investment-Shinhan Capital, Mirae Asset Capital, SEEDS Capital, Wooshin Venture Investment |
| Mar 7, 2017 | ImmunoMet Therapeutics | $5.0M Series B | — | Sungwuk Kim, InterVest, Mirae Asset Venture Investment, NHN Ventures, SL Investment |
| Dec 8, 2016 | Eutilex | $18.1M Series A | — | DS Asset Management, Kolon Investment, SNU Bio Angel |
| Mar 8, 2016 | ImmunoMet Therapeutics | $5.2M Series A | Jae Joon Kim | Aju Tech, Metavest Capital |